Link Cell Therapies, a cancer cell treatment company, has initiated clinical delivery of its lead project LNK001, a CAR-T therapy...
-
-
Recent Updates
- Link Cell Therapies Expands Logic-Gated CAR-T Therapy Clinical Delivery, Boosts Executive Team, and Increases Series A Funding to $90 Million
- China Hosts 9th Nanning Overseas Talent Competition
- Laopu Gold opens its largest mainland China store at Shanghai’s Plaza 66
- ProWine Shanghai: ‘Integration of business and leisure’
- Hong Kong ETFs Target Chinese Insurer Demand for Overseas Assets
- Hong Kong Stock Exchange Welcomes Four New ETFs Tracking Cross-Market Indexes
- Debating Rare Earths: US-China Tariff Reductions Address Basic Goods, Watchful Eye on Limitation
- New Trade Framework Between US and China Proposes Tariff Reduction on Over $30 Billion of Goods Each
- US-China Tariff Talks Yield Potential Product Tax Reductions
- WorldSkills Team Canada 2026 Celebrates Outstanding Results at WorldSkills Shanghai 2026
Blogroll